Awards & Advancement

Crescendo secures $56 Million in Series C financing

Wednesday, September 14, 2011 11:25 AM

Crescendo Bioscience has completed a $31 million Series C equity financing and entered into a strategic investment agreement with Myriad Genetics for $25 million, raising a total of $56 million. The Series C investment round was led by aeris CAPITAL and was joined by existing investors Mohr Davidow Ventures, Kleiner Perkins Caufield & Byers and other investors.

More... »

Former Genzyme chief donates $10 million to MGH

Wednesday, September 14, 2011 11:00 AM

Retired biotechnology executive Henri A. Termeer, who built Genzyme into the largest US company specializing in drugs to treat rare genetic disorders, is donating $10 million to Massachusetts General Hospital to establish it as a world leader in personalized medicine, according to the Boston Globe.

More... »

DeBoer joins Advanced Clinical

Tuesday, September 13, 2011 11:59 AM

Advanced Clinical has reported that Ami DeBoer has joined the company as director of recruiting. As director of recruiting, DeBoer is responsible for recruitment operations and managing Advanced Clinical’s Midwest and East Coast recruiting teams. She is also responsible for full life-cycle recruitment, executing on contract and direct hire search assignments for the company's clients.

More... »

Trizzino joins Immunovaccine as CEO

Monday, September 12, 2011 12:44 PM

Immunovaccine has named John J. Trizzino chief executive officer, effective October 1, 2011. Trizzino will also be appointed to the company's board of directors.

More... »

FibroGen names VP, technical development

Monday, September 12, 2011 12:31 PM

FibroGen has named Michael Martinelli, Ph.D., vice president, technical development. In this role, Martinelli is responsible for the chemistry, manufacturing, and controls (CMC) development activities for FibroGen’s most advanced small molecule clinical candidates.

More... »

Tensha completes $15 million Seires A financing round

Monday, September 12, 2011 12:22 PM

Tensha Therapeutics has raised $15 million in a Series A financing to advance the development of small molecule bromodomain inhibitors for the treatment of cancer and other conditions by regulating the transcription of disease-associated genes. The company's lead program, presently in preclinical development, is a first-in-class small molecule aimed at the treatment of BRD4-NUT midline carcinoma (a rare, invariably fatal cancer), acute myeloid leukemias, multiple myeloma, and other malignancies. HealthCare Ventures is the sole investor in the financing.

More... »

Valeritas raises $150 million in Series C financing

Monday, September 12, 2011 11:58 AM

Valeritas has completed a significant Series C round of financing of $150 million. This financing will support the commercialization of the V-Go disposable insulin delivery device, which provides basal-bolus insulin therapy for adult patients with diabetes who require insulin.

More... »

WCCT names Affrime senior VP

Friday, September 9, 2011 01:21 PM

West Coast Clinical Trials has named Melton Affrime senior vice president, research and development, to further develop their growing clinical research capabilities.

More... »

Prolog joins Wolters Kluwer Pharma

Friday, September 9, 2011 12:56 PM

Wolters Kluwer Pharma Solutions has named Henry Prolog vice president, data strategy, acquisitions & services. Prolog will manage the supply of data and information sets from PBM's, wholesalers, retail pharmacies and hospitals. He is responsible for setting data strategy for the company's healthcare analytics business. He also will determine the data agreements necessary to support top line revenue growth. 

More... »

Bailes joins NorthShore University HealthSystem

Friday, September 9, 2011 12:32 PM

NorthShore University HealthSystem has named Julian E. Bailes, M.D., chairman of the department of neurosurgery and co-director of the NorthShore Neurological Institute.

More... »